Cassava Sciences ( SAVA) stock dropped 87% on Monday to close the day’s trading at $4.29 a shares. Cassava is a biotechnology ...

Cassava Sciences stock plummeted Monday — wiping out more than three-quarters of its value — after the company's Alzheimer's treatment failed in Phase 3 testing. Please watch the video at ...

As of September 30, 2024, Alector has $457.2 million in cash, cash equivalents, and investments, which the company continues to expect will provide runway through 2026. Alector plans to provide ...

A study finds people exposed to wildfire pollution have an 18 percent higher risk for dementia, compared to just a one ...

Financial struggles—late or missed bill payments, bad credit scores, etc.—can be one of the first noticeable signs of ...

Cassava Sciences, a US biotech developing a novel, investigational treatment for Alzheimer’s disease (AD) dementia, was ...

A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid ...

About 40% of dementia cases could be prevented or delayed by healthy lifestyle choices and preventive medicine. Here's a tool ...

There may finally be a way of letting needed medication through the defenses of the brain, paving the way for the treatment of neurological disorders.

Researchers have uncovered how certain genetic mutations lead to unique spherical amyloid plaques in inherited forms of ...

By Christopher Gannatti, CFAIn November 2024, it isn’t difficult to find all sorts of perspectives on the so-called ...

A living will or living trust can also provide additional instructions for how your sister wishes her estate to be handled after her death. Crucially, a trust would help her executor, or the ...